Celesta Capital — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Berkeley Lights (now Bruker Cellular Analysis) develops the Beacon optofluidic system for single-cell functional analysis, enabling researchers to profile live single cells to discover therapeutic antibodies, interrogate T cells, identify cell therapies, and accelerate cell line development.
BiotechDeep TechHardwareEmeryville, US
Ming Wu(Director)inIgor Khandros(Executive Officer, Director)
BoardMichael Marks(Director)Lip-Bu Tan Tan(Director)Michael Moritz(Director)William Davidow(Director)
Co-investorsCelesta CapitalCota CapitalKhosla VenturesOpen Field CapitalShangBay Capital LLCWalden Catalyst+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.